Effect of Dirithromycin on Haemophilus influenzae Infection of the Respiratory Mucosa

ABSTRACT Macrolides have properties other than their antibiotic action which may benefit patients with airway infections. We have investigated the effect of dirithromycin (0.125 to 8.0 μg/ml) on the interaction of Haemophilus influenzae with respiratory mucosa in vitro using human nasal epithelium, adenoid tissue, and bovine trachea. Dirithromycin did not affect the ciliary beat frequency of the nasal epithelium or the transport of mucus on bovine trachea, but dirithromycin (1 μg/ml) did reduce the slowing of the ciliary beat frequency and the damage to the nasal epithelium caused byH. influenzae broth culture filtrate. Amoxicillin (2 μg/ml) did not reduce the effects of the H. influenzaebroth culture filtrate. H. influenzae infection of the organ cultures for 24 h caused mucosal damage and the loss of ciliated cells. Bacteria adhered to damaged epithelium and to a lesser extent to mucus and unciliated cells. Incubation of H. influenzae with dirithromycin at sub-MICs (0.125 and 0.5 μg/ml) prior to infection of the organ cultures did not reduce the mucosal damage caused by bacterial infection. By contrast, incubation of adenoid tissue with dirithromycin (0.125 to 1.0 μg/ml) for 4 h prior to assembling the organ culture reduced the mucosal damage caused by subsequent H. influenzae infection by as much as 50%. The number of bacteria adherent to the mucosa was reduced, although the tissue that had been incubated with dirithromycin (0.125 and 0.5 μg/ml) did not inhibit bacterial growth. This was achieved by a reduction in the amount of damaged epithelium to which H. influenzae adhered and a reduction in the density of bacteria adhering to mucus. We conclude that dirithromycin at concentrations achievable in vivo markedly reduces the mucosal damage caused byH. influenzae infection due to a cytoprotective effect.

[1]  G. Taylor,et al.  The effect of bacterial toxins on levels of intracellular adenosine nucleotides and human ciliary beat frequency. , 1996, Pulmonary pharmacology.

[2]  R. Wilson,et al.  The biology of bacterial colonization and invasion of the respiratory mucosa. , 1996, The European respiratory journal.

[3]  R. Wilson,et al.  A human respiratory-tissue organ culture incorporating an air interface. , 1996, American journal of respiratory and critical care medicine.

[4]  J. Ruiz,et al.  Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. , 1995, American journal of respiratory and critical care medicine.

[5]  R. Davies,et al.  Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells. , 1995, The European respiratory journal.

[6]  B. Meyboom-de Jong,et al.  Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. , 1995, Thorax.

[7]  R. Wilson,et al.  The ciliary transportability of sputum is slow on the mucus-depleted bovine trachea. , 1995, American journal of respiratory and critical care medicine.

[8]  P. J. Byard,et al.  Effect of high-dose ibuprofen in patients with cystic fibrosis. , 1995, The New England journal of medicine.

[9]  R. Wilson,et al.  Chemotherapy for chronic bronchitis. Controversies. , 1995, Presse medicale.

[10]  M. Cazzola,et al.  Pulmonary penetration of dirithromycin in patients suffering from acute exacerbation of chronic bronchitis. , 1994, Pulmonary pharmacology.

[11]  E. Tanaka,et al.  Interaction of Pseudomonas aeruginosa with human respiratory mucosa in vitro. , 1994, The European respiratory journal.

[12]  K. Matsushima,et al.  Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases , 1994, Infection and immunity.

[13]  G. Taylor,et al.  The effect of erythromycin on Pseudomonas aeruginosa and neutrophil mediated epithelial damage. , 1994, The Journal of antimicrobial chemotherapy.

[14]  S. Umeki,et al.  Anti-inflammatory action of erythromycin. Its inhibitory effect on neutrophil NADPH oxidase activity. , 1993, Chest.

[15]  E. Tagaya,et al.  Effect of macrolide antibiotics on ciliary motility in rabbit airway epithelium in‐vitro , 1993, The Journal of pharmacy and pharmacology.

[16]  R. Read,et al.  Haemophilus influenzae infection of human respiratory mucosa in low concentrations of antibiotics. , 1993, The American review of respiratory disease.

[17]  Y. Ichikawa,et al.  Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. , 1993, The American review of respiratory disease.

[18]  J. Macfarlane,et al.  Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community , 1993, The Lancet.

[19]  T. Murphy,et al.  Bacterial infection in chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.

[20]  A. Brain,et al.  Interaction of nontypable Haemophilus influenzae with human respiratory mucosa in vitro. , 1991, The Journal of infectious diseases.

[21]  B. Rosenstein,et al.  Risks of alternate-day prednisone in patients with cystic fibrosis. , 1991, Pediatrics.

[22]  W. Goldman,et al.  Effects of Bordetella pertussis infection on human respiratory epithelium in vivo and in vitro , 1991, Infection and immunity.

[23]  J. Fagon,et al.  Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. , 1990, The American review of respiratory disease.

[24]  T. Izumi,et al.  [Long-term therapeutic effects of erythromycin and newquinolone antibacterial agents on diffuse panbronchiolitis]. , 1990, Nihon Kyobu Shikkan Gakkai zasshi.

[25]  J. El Benna,et al.  Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neutrophils. , 1989, The Journal of antimicrobial chemotherapy.

[26]  S. Kudoh,et al.  [Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis]. , 1987, Nihon Kyobu Shikkan Gakkai zasshi.

[27]  T. Inzana,et al.  Loss of ciliary activity in organ cultures of rat trachea treated with lipo-oligosaccharide from Haemophilus influenzae. , 1986, Journal of medical microbiology.

[28]  R. Wilson,et al.  Effect of bacterial products on human ciliary function in vitro. , 1985, Thorax.

[29]  M. Hodson,et al.  Cystic fibrosis serum does not inhibit human ciliary beat frequency. , 1983, The American review of respiratory disease.

[30]  F. W. Denny Effect of a toxin produced by Haemophilus influenzae on ciliated respiratory epithelium. , 1974, The Journal of infectious diseases.

[31]  W. G. Wyllie,et al.  Bronchiectasis , 1908, The Hospital.

[32]  G. Taylor,et al.  Effect of salmeterol on Pseudomonas aeruginosa infection of respiratory mucosa. , 1997, American journal of respiratory and critical care medicine.

[33]  S. Kohno,et al.  Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection. , 1997, American journal of respiratory and critical care medicine.

[34]  J. M. Harris,et al.  Acute infective exacerbations of chronic bronchitis. , 1995, QJM : monthly journal of the Association of Physicians.

[35]  H. Mukae,et al.  A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. , 1993, The American review of respiratory disease.

[36]  Eriko Yamaguchi,et al.  Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. , 1991, Respiration; international review of thoracic diseases.

[37]  R. Stockley,et al.  Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. , 1991, American journal of respiratory cell and molecular biology.

[38]  S. Goswami,et al.  Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. , 1990, The American review of respiratory disease.

[39]  J. Fagon,et al.  Use of the Protected Specimen Brush Technique in 54 Mechanically Ventilated Patients , 1990 .

[40]  Y. Mizushima,et al.  Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages. , 1989, Drugs under experimental and clinical research.